Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in context

Background: Flaviviruses such as Zika cause sporadic pandemic outbreaks worldwide. There is an urgent need for anti-Zika virus (ZIKV) drugs to prevent mother-to-child transmission of ZIKV, new infections in high-risk populations, and the infection of medical personnel in ZIKV-affected areas. Methods...

Full description

Bibliographic Details
Main Authors: Alicia Martinez-Lopez, Mirjana Persaud, Maritza Puray Chavez, Hongjie Zhang, Lijun Rong, Shufeng Liu, Tony T. Wang, Stefan G. Sarafianos, Felipe Diaz-Griffero
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396419305833
_version_ 1818543639797694464
author Alicia Martinez-Lopez
Mirjana Persaud
Maritza Puray Chavez
Hongjie Zhang
Lijun Rong
Shufeng Liu
Tony T. Wang
Stefan G. Sarafianos
Felipe Diaz-Griffero
author_facet Alicia Martinez-Lopez
Mirjana Persaud
Maritza Puray Chavez
Hongjie Zhang
Lijun Rong
Shufeng Liu
Tony T. Wang
Stefan G. Sarafianos
Felipe Diaz-Griffero
author_sort Alicia Martinez-Lopez
collection DOAJ
description Background: Flaviviruses such as Zika cause sporadic pandemic outbreaks worldwide. There is an urgent need for anti-Zika virus (ZIKV) drugs to prevent mother-to-child transmission of ZIKV, new infections in high-risk populations, and the infection of medical personnel in ZIKV-affected areas. Methods: Here, we showed that the small molecule 6-deoxyglucose-diphyllin (DGP) exhibited anti-ZIKV activity both in vitro and in vivo. DGP potently blocked ZIKV infection across all human and monkey cell lines tested. DGP also displayed broad-spectrum antiviral activity against other flaviviruses. Remarkably, DGP prevented ZIKV-induced mortality in mice lacking the type I interferon receptor (Ifnar1−/−). Cellular and virological experiments showed that DGP blocked ZIKV at a pre-fusion step or during fusion, which prevented the delivery of viral contents into the cytosol of the target cell. Mechanistic studies revealed that DGP prevented the acidification of endosomal/lysosomal compartments in target cells, thus inhibiting ZIKV fusion with cellular membranes and infection. Findings: These investigations revealed that DGP inhibits ZIKV infection in vitro and in vivo. Interpretation: The small molecule DGP has great potential for preclinical studies and the ability to inhibit ZIKV infection in humans. Keywords: Zika, Glycosylated diphyllin, Fusion, Endosomal, pH, Ifnar1−/−
first_indexed 2024-12-11T22:38:03Z
format Article
id doaj.art-c501f0f7912b4b21a318e5ad574195a1
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-12-11T22:38:03Z
publishDate 2019-09-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-c501f0f7912b4b21a318e5ad574195a12022-12-22T00:47:54ZengElsevierEBioMedicine2352-39642019-09-0147269283Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in contextAlicia Martinez-Lopez0Mirjana Persaud1Maritza Puray Chavez2Hongjie Zhang3Lijun Rong4Shufeng Liu5Tony T. Wang6Stefan G. Sarafianos7Felipe Diaz-Griffero8Department of Microbiology and Immunology, Albert Einstein College of Medicine Bronx, NY 10461, USADepartment of Microbiology and Immunology, Albert Einstein College of Medicine Bronx, NY 10461, USALaboratory of Biochemical Pharmacology Emory University, Emory University, Atlanta, GA 30322, USASchool of Chinese Medicine, Hong Kong Baptist University, 7 Baptist University Road, Kowloon Tong, Hong Kong SAR, People's Republic of ChinaMicrobiology and Immunology College of Medicine, University of Illinois at Chicago, IL 60612, USALaboratory of Vector-borne Viral Diseases, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20903, USALaboratory of Vector-borne Viral Diseases, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20903, USALaboratory of Biochemical Pharmacology Emory University, Emory University, Atlanta, GA 30322, USADepartment of Microbiology and Immunology, Albert Einstein College of Medicine Bronx, NY 10461, USA; Corresponding author at: Albert Einstein College of Medicine, 1301 Morris Park, Price Center 501, New York, NY 10461, USA.Background: Flaviviruses such as Zika cause sporadic pandemic outbreaks worldwide. There is an urgent need for anti-Zika virus (ZIKV) drugs to prevent mother-to-child transmission of ZIKV, new infections in high-risk populations, and the infection of medical personnel in ZIKV-affected areas. Methods: Here, we showed that the small molecule 6-deoxyglucose-diphyllin (DGP) exhibited anti-ZIKV activity both in vitro and in vivo. DGP potently blocked ZIKV infection across all human and monkey cell lines tested. DGP also displayed broad-spectrum antiviral activity against other flaviviruses. Remarkably, DGP prevented ZIKV-induced mortality in mice lacking the type I interferon receptor (Ifnar1−/−). Cellular and virological experiments showed that DGP blocked ZIKV at a pre-fusion step or during fusion, which prevented the delivery of viral contents into the cytosol of the target cell. Mechanistic studies revealed that DGP prevented the acidification of endosomal/lysosomal compartments in target cells, thus inhibiting ZIKV fusion with cellular membranes and infection. Findings: These investigations revealed that DGP inhibits ZIKV infection in vitro and in vivo. Interpretation: The small molecule DGP has great potential for preclinical studies and the ability to inhibit ZIKV infection in humans. Keywords: Zika, Glycosylated diphyllin, Fusion, Endosomal, pH, Ifnar1−/−http://www.sciencedirect.com/science/article/pii/S2352396419305833
spellingShingle Alicia Martinez-Lopez
Mirjana Persaud
Maritza Puray Chavez
Hongjie Zhang
Lijun Rong
Shufeng Liu
Tony T. Wang
Stefan G. Sarafianos
Felipe Diaz-Griffero
Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in context
EBioMedicine
title Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in context
title_full Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in context
title_fullStr Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in context
title_full_unstemmed Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in context
title_short Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virusResearch in context
title_sort glycosylated diphyllin as a broad spectrum antiviral agent against zika virusresearch in context
url http://www.sciencedirect.com/science/article/pii/S2352396419305833
work_keys_str_mv AT aliciamartinezlopez glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT mirjanapersaud glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT maritzapuraychavez glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT hongjiezhang glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT lijunrong glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT shufengliu glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT tonytwang glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT stefangsarafianos glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext
AT felipediazgriffero glycosylateddiphyllinasabroadspectrumantiviralagentagainstzikavirusresearchincontext